US Patent Issued to ABIONYX PHARMA on July 22 for "CER-001 therapy for treating kidney disease" (French, Italian Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,705, issued on July 22, was assigned to ABIONYX PHARMA SA (Balma, France).

"CER-001 therapy for treating kidney disease" was invented by Jean-Louis Dasseux (Toulouse, France), Laura Calabresi (Milan), Cyrille Tupin (Castelmaurou, France), Ronald Barbaras (Seilh, France) and Constance Peyrottes (Le Castera, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is the use of CER-001, a negatively charged lipoprotein complex which comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG) for treating kidney diseases, and methods for treating a subje...